Pemetrexed (Alimta)
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Pemetrexed (Alimta), covering 2007-11-06 to 2026-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer [Phase 2]